Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Can a 70-gene signature provide useful prognostic information in patients with node-negative breast cancer?

Nature Clinical Practice Oncology volume 4, pages 216–217 (2007)Cite this article

boxed-textBuyse M et al. (2006) Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst 98: 1183–1192

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Bast RC Jr et al. (2001) 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19: 1865–1878

    Article  Google Scholar 

  2. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365: 1687–1717

  3. Brenton JD et al. (2005) Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol 23: 7350–7360

    Article  CAS  Google Scholar 

  4. van de Vijver MJ et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999–2009

    Article  CAS  Google Scholar 

  5. Simon R (2006) Development and evaluation of therapeutically relevant predictive classifiers using gene expression profiling [editorial]. J Natl Cancer Inst 98: 1169–1171

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. O Modlich is a Senior Scientist in the Institute of Chemical Oncology, and H Bojar is Professor in Physiological Chemistry, and Director of the Institute of Chemical Oncology at the University of Düsseldorf, Germany.,

    Olga Modlich & Hans Bojar

Authors
  1. Olga Modlich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hans Bojar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Olga Modlich.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Modlich, O., Bojar, H. Can a 70-gene signature provide useful prognostic information in patients with node-negative breast cancer?. Nat Rev Clin Oncol 4, 216–217 (2007). https://doi.org/10.1038/ncponc0747

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0747

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing